Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid to reduce blood loss in proximal femur surgery
NCT02164565Phase 4Withdrawn
- Sponsor
- Emek Medical Center
- Start
- Jun 2014
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tranexamic acid in Femur fracture, sponsored by Emek Medical Center. Planned start Jun 2014; status: withdrawn.
02
Drugs
tranexamic acid
03
Conditions
Femur fracture
Beyond the preview
Go deeper on NCT02164565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02164565.